Research and Funding

Funding Opportunities

T1 Translational Research: Novel interventions for prevention and treatment of age-related conditions (R21)

Funding Number: PAS-11-280
Funding Type: PAS
Release Date: July 25, 2011
Expiration Date: September 8, 2014
Web Site:
This funding opportunity announcement (FOA) encourages exploratory/developmental R21 research projects to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. For projects proposing basic research that is being conducted in animal models, the potential to treat a clinical age-related pathology must be clearly stated in the proposal. Direct relevance of the data to a clinical aging condition must be established and clearly stated in the application.